A new alpha-emitting radiopharmaceutical therapy (RPT) for advanced prostate cancer was well tolerated, with no dose-limiting ...

In patients with extensive-stage small cell lung cancer (ES-SCLC), tarlatamab, a bispecific T-cell engager, plus durvalumab as first-line maintenance therapy extended median overall survival by more ...

Large language models (LLMs), such as ChatGPT and Claude, are increasingly being used to provide health information to the ...

Rare variants in a gene involved in early development have been linked to a range of dental differences in people, including ...

Researchers analyzed reports from 9,150 US adults and found that current or previous GLP-1/GIP use rose from 8.2% to 12% ...

Researchers compared semaglutide-treated male and female rats with pair-fed animals receiving the same amount and type of ...

Researchers analyzed beverage intake and oral microbiome data from 5,598 adults across three US cohorts and found that ...

Researchers analyzed vaginal microbiota, metabolites, and psychological questionnaire scores in 105 young Italian women and ...

New research led by the University of Michigan contains valuable insights for public health officials and communities in ...

Today, the American Heart Association, American Academy of Pediatrics, American College of Obstetricians and Gynecologists ...

African health experts have called for an immediate and coordinated response from pan-African authorities after new cases of ...

A new drug is effective at decreasing recurrence of and death from endometrial cancer, a landmark international study shows.